Danaher Co. (NYSE:DHR) to Issue $0.27 Quarterly Dividend

Danaher Co. (NYSE:DHR) announced a quarterly dividend on Tuesday, May 7th, RTT News reports. Investors of record on Friday, June 28th will be paid a dividend of 0.27 per share by the conglomerate on Friday, July 26th. This represents a $1.08 annualized dividend and a yield of 0.43%.

Danaher has raised its dividend payment by an average of 13.4% annually over the last three years and has raised its dividend annually for the last 1 consecutive years. Danaher has a dividend payout ratio of 12.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Danaher to earn $8.71 per share next year, which means the company should continue to be able to cover its $1.08 annual dividend with an expected future payout ratio of 12.4%.

Danaher Stock Up 0.3 %

Shares of DHR stock opened at $249.58 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The stock has a market cap of $184.86 billion, a PE ratio of 42.30, a price-to-earnings-growth ratio of 3.82 and a beta of 0.83. The business’s fifty day moving average is $248.27 and its 200-day moving average is $233.19. Danaher has a 1 year low of $182.09 and a 1 year high of $259.00.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same period in the previous year, the company earned $2.36 earnings per share. Danaher’s revenue was down 2.6% compared to the same quarter last year. Equities analysts expect that Danaher will post 7.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Robert W. Baird lifted their price target on shares of Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 24th. KeyCorp increased their target price on Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. Barclays lifted their target price on Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 24th. Finally, Raymond James boosted their price objective on shares of Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Six equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $267.31.

Insiders Place Their Bets

In other news, SVP Daniel Raskas sold 23,757 shares of the company’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the sale, the senior vice president now owns 38,102 shares in the company, valued at approximately $9,601,704. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the sale, the senior vice president now directly owns 4,244 shares in the company, valued at $1,029,891.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the transaction, the senior vice president now owns 38,102 shares in the company, valued at $9,601,704. The disclosure for this sale can be found here. Insiders have sold 103,984 shares of company stock valued at $25,997,094 over the last three months. 10.90% of the stock is currently owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.